158 related articles for article (PubMed ID: 11559563)
1. Antigenicity of fusion proteins from sarcoma-associated chromosomal translocations.
Worley BS; van den Broeke LT; Goletz TJ; Pendleton CD; Daschbach EM; Thomas EK; Marincola FM; Helman LJ; Berzofsky JA
Cancer Res; 2001 Sep; 61(18):6868-75. PubMed ID: 11559563
[TBL] [Abstract][Full Text] [Related]
2. Identification and epitope enhancement of a PAX-FKHR fusion protein breakpoint epitope in alveolar rhabdomyosarcoma cells created by a tumorigenic chromosomal translocation inducing CTL capable of lysing human tumors.
van den Broeke LT; Pendleton CD; Mackall C; Helman LJ; Berzofsky JA
Cancer Res; 2006 Feb; 66(3):1818-23. PubMed ID: 16452243
[TBL] [Abstract][Full Text] [Related]
3. Detection and induction of CTLs specific for SYT-SSX-derived peptides in HLA-A24(+) patients with synovial sarcoma.
Sato Y; Nabeta Y; Tsukahara T; Hirohashi Y; Syunsui R; Maeda A; Sahara H; Ikeda H; Torigoe T; Ichimiya S; Wada T; Yamashita T; Hiraga H; Kawai A; Ishii T; Araki N; Myoui A; Matsumoto S; Umeda T; Ishii S; Kawaguchi S; Sato N
J Immunol; 2002 Aug; 169(3):1611-8. PubMed ID: 12133991
[TBL] [Abstract][Full Text] [Related]
4. Peptides spanning the junctional region of both the abl/bcr and the bcr/abl fusion proteins bind common HLA class I molecules.
Berke Z; Andersen MH; Pedersen M; Fugger L; Zeuthen J; Haurum JS
Leukemia; 2000 Mar; 14(3):419-26. PubMed ID: 10720136
[TBL] [Abstract][Full Text] [Related]
5. Crisscross CTL induction by SYT-SSX junction peptide and its HLA-A*2402 anchor substitute.
Ida K; Kawaguchi S; Sato Y; Tsukahara T; Nabeta Y; Sahara H; Ikeda H; Torigoe T; Ichimiya S; Kamiguchi K; Wada T; Nagoya S; Hiraga H; Kawai A; Ishii T; Araki N; Myoui A; Matsumoto S; Ozaki T; Yoshikawa H; Yamashita T; Sato N
J Immunol; 2004 Jul; 173(2):1436-43. PubMed ID: 15240740
[TBL] [Abstract][Full Text] [Related]
6. Peptides derived from the whole sequence of BCR-ABL bind to several class I molecules allowing specific induction of human cytotoxic T lymphocytes.
Buzyn A; Ostankovitch M; Zerbib A; Kemula M; Connan F; Varet B; Guillet JG; Choppin J
Eur J Immunol; 1997 Aug; 27(8):2066-72. PubMed ID: 9295046
[TBL] [Abstract][Full Text] [Related]
7. Immune profiles of desmoplastic small round cell tumor and synovial sarcoma suggest different immunotherapeutic susceptibility upfront compared to relapse specimens.
Wedekind MF; Haworth KB; Arnold M; Stanek JR; Lee D; Cripe TP
Pediatr Blood Cancer; 2018 Nov; 65(11):e27313. PubMed ID: 30015384
[TBL] [Abstract][Full Text] [Related]
8. Specific binding of leukemia oncogene fusion protein peptides to HLA class I molecules.
Bocchia M; Wentworth PA; Southwood S; Sidney J; McGraw K; Scheinberg DA; Sette A
Blood; 1995 May; 85(10):2680-4. PubMed ID: 7742526
[TBL] [Abstract][Full Text] [Related]
9. Mapping of HLA class I binding motifs in forty-four fusion proteins involved in human cancers.
Gambacorti-Passerini C; Bertazzoli C; Dermime S; Scardino A; Schendel D; Parmiani G
Clin Cancer Res; 1997 May; 3(5):675-83. PubMed ID: 9815736
[TBL] [Abstract][Full Text] [Related]
10. Use of two predictive algorithms of the world wide web for the identification of tumor-reactive T-cell epitopes.
Lu J; Celis E
Cancer Res; 2000 Sep; 60(18):5223-7. PubMed ID: 11016651
[TBL] [Abstract][Full Text] [Related]
11. Specific human cellular immunity to bcr-abl oncogene-derived peptides.
Bocchia M; Korontsvit T; Xu Q; Mackinnon S; Yang SY; Sette A; Scheinberg DA
Blood; 1996 May; 87(9):3587-92. PubMed ID: 8611681
[TBL] [Abstract][Full Text] [Related]
12. Two brc-abl junction peptides bind HLA-A3 molecules and allow specific induction of human cytotoxic T lymphocytes.
Greco G; Fruci D; Accapezzato D; Barnaba V; Nisini R; Alimena G; Montefusco E; Vigneti E; Butler R; Tanigaki N; Tosi R
Leukemia; 1996 Apr; 10(4):693-9. PubMed ID: 8618449
[TBL] [Abstract][Full Text] [Related]
13. Detection of common chromosomal translocations in small round blue cell pediatric tumors.
Ponce-Castañeda MV; García-Chéquer AJ; Eguía Aguilar P; Abundes-Ramírez MA; Hernández-Angeles A; Nieto-Martínez K; Gómez-Laguna L; Sadowinski-Pine S; Cabrera-Muñoz Mde L
Arch Med Res; 2014 Feb; 45(2):143-51. PubMed ID: 24486246
[TBL] [Abstract][Full Text] [Related]
14. Peptide sequences binding to MHC class I proteins.
Smith MH; Lam KS; Hersh EM; Lebl M; Grimes WJ
Mol Immunol; 1994 Dec; 31(18):1431-7. PubMed ID: 7823969
[TBL] [Abstract][Full Text] [Related]
15. Identification of gp100-derived, melanoma-specific cytotoxic T-lymphocyte epitopes restricted by HLA-A3 supertype molecules by primary in vitro immunization with peptide-pulsed dendritic cells.
Kawashima I; Tsai V; Southwood S; Takesako K; Celis E; Sette A
Int J Cancer; 1998 Nov; 78(4):518-24. PubMed ID: 9797143
[TBL] [Abstract][Full Text] [Related]
16. Identification of new melanoma epitopes on melanosomal proteins recognized by tumor infiltrating T lymphocytes restricted by HLA-A1, -A2, and -A3 alleles.
Kawakami Y; Robbins PF; Wang X; Tupesis JP; Parkhurst MR; Kang X; Sakaguchi K; Appella E; Rosenberg SA
J Immunol; 1998 Dec; 161(12):6985-92. PubMed ID: 9862734
[TBL] [Abstract][Full Text] [Related]
17. Improved generation of HLA class I/peptide tetramers.
Sato Y; Sahara H; Tsukahara T; Kondo M; Hirohashi Y; Nabeta Y; Kawaguchi S; Ikeda H; Torigoe T; Ichimiya S; Tamura Y; Wada T; Yamashita T; Goto M; Takasu H; Sato N
J Immunol Methods; 2002 Dec; 271(1-2):177-84. PubMed ID: 12445740
[TBL] [Abstract][Full Text] [Related]
18. The peptide binding specificity of HLA class I molecules is largely allele-specific and non-overlapping.
Carreno BM; Koenig S; Coligan JE; Biddison WE
Mol Immunol; 1992 Sep; 29(9):1131-40. PubMed ID: 1379681
[TBL] [Abstract][Full Text] [Related]
19. HLA-A1 and HLA-A3 T cell epitopes derived from influenza virus proteins predicted from peptide binding motifs.
DiBrino M; Tsuchida T; Turner RV; Parker KC; Coligan JE; Biddison WE
J Immunol; 1993 Dec; 151(11):5930-5. PubMed ID: 7504010
[TBL] [Abstract][Full Text] [Related]
20. Identification of HLA-A3 and -B7-restricted CTL response to hepatitis C virus in patients with acute and chronic hepatitis C.
Chang KM; Gruener NH; Southwood S; Sidney J; Pape GR; Chisari FV; Sette A
J Immunol; 1999 Jan; 162(2):1156-64. PubMed ID: 9916747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
